The stem cell transplant program in Pakistan--the first decade

Bone Marrow Transplantation
Ts ShamsiS Ansari

Abstract

Stem cell transplantation is curative in a number of otherwise fatal hematological diseases. In Pakistan, SCT was started in October 1995 at Dr Ziauddin Hospital by Dr Tahir Shamsi and his team. The first case was of a young man suffering from AML. In 1999, allogeneic BMT was started at Bismillah Taqee Institute of Health Sciences and Blood Diseases Centre, Karachi. In 2001, the Armed Forces Bone Marrow Transplant Centre, started functioning. Since then, over 350 allogeneic stem cell transplants have been carried out in these latter two centers. Another 50 autologous procedures were carried out in all centers. In 2004, a third center started transplants at the Aga Khan Hospital. The main indications for transplant are aplastic anemia, beta-thalassemia major and hematological malignancies. HLA-identical sibling donors provide stem cells for the recipient. In 70% of cases, a matched donor is identified. In sharp contrast to the rest of the world, the majority of transplants are allogeneic, donor-recipient pairs are CMV positive and fungal infection, tuberculosis and malaria are particular problems. The early results are promising, with transplant-related mortality reported to be 10-20%, whereas long-term survival is reported to b...Continue Reading

Citations

Mar 2, 2010·Bone Marrow Transplantation·A YoshimiUNKNOWN Asia-Pacific Blood and Marrow Transplantation Group (APBMT)
Apr 21, 2010·Nature Reviews. Clinical Oncology·Matthew P StroutNancy Berliner
Jan 29, 2013·Hematology Reports·Natasha AliNehal Masood
Aug 15, 2009·Current Opinion in Hematology·Alois Gratwohl, Helen Baldomero
Jan 20, 2012·Journal of Pediatric Hematology/oncology·Shahid Mahmood BaigSyeda Marriam Bakhtiar
Nov 17, 2015·Expert Review of Hematology·Amer M ZeidanB Douglas Smith
Jan 23, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Rajat KumarWael Saber
Jan 30, 2010·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Mahmoud AljurfHassan El Solh
Aug 8, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Waleed Al-HerzUNKNOWN USIDNET Consortium
Oct 28, 2010·Pediatric Blood & Cancer·Deepak BansalR K Marwaha
Sep 15, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcie TomblynUNKNOWN Centers for Disease Control and Prevention
Oct 3, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Wafa M ElbjeiramiAyad Ahmed Hussein
Jan 20, 2015·Bone Marrow Transplantation·A A HamidiehA Ghavamzadeh
May 3, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Jordi RelloUNKNOWN ESGCIP and ESGITM
Oct 4, 2016·Zeitschrift für Gesundheitswissenschaften = Journal of public health·Mehwesh TajTahir Sultan Shamsi
Sep 13, 2016·Bone Marrow Transplantation·A A HusseinUNKNOWN Pediatric Cancer Working Committee of the Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group
Mar 30, 2017·Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation·Zühre KayaEnes Değirmenci
Dec 7, 2018·Journal of Global Oncology·Mehreen A KhanSyed K Mahmood
Sep 22, 2018·Bone Marrow Transplantation·Muhammad Sabih SaleemShahrukh K Hashmi
Dec 6, 2012·Experimental Hematology & Oncology·Natasha AliNehal Masood

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.